Results 151 to 160 of about 571,237 (168)
Some of the next articles are maybe not open access.
Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency
American Journal of Medical Genetics Part A, 2017Biallelic likely pathogenic variants in SLC52A2 and SLC52A3 cause riboflavin transporter deficiency. It is characterized by muscle weakness, ataxia, progressive ponto‐bulbar palsy, amyotrophy, and sensorineural hearing loss. Oral riboflavin halts disease progression and may reverse symptoms.
Graeme A. M. Nimmo +4 more
openaire +2 more sources
Journal of Neurology, Neurosurgery & Psychiatry, 2020
ObjectiveRiboflavin transporter deficiencies (RTDs), involving SLC52A3 and SLC52A2 genes, have recently been related to Brown-Vialetto-Van Laere (BVVL) syndrome, a hereditary paediatric condition associating motor neuropathy (MN) and deafness. BVVL/RTD has rarely been reported in adult patients, but is probably underdiagnosed due to poor knowledge and ...
Carreau, Christophe +10 more
openaire +2 more sources
ObjectiveRiboflavin transporter deficiencies (RTDs), involving SLC52A3 and SLC52A2 genes, have recently been related to Brown-Vialetto-Van Laere (BVVL) syndrome, a hereditary paediatric condition associating motor neuropathy (MN) and deafness. BVVL/RTD has rarely been reported in adult patients, but is probably underdiagnosed due to poor knowledge and ...
Carreau, Christophe +10 more
openaire +2 more sources
P385 Hypotonic infant with riboflavin transporter deficiency due to slc52a2 mutations
Posters, 2017Introduction Biologically active forms of riboflavin, which is an important factor in myelin synthesis, are important cofactors of carbohydrate, amino acid, and lipid metabolism. The mutations in the riboflavin transporter genes (SLC52A2, SLC52A3) cause riboflavin transporter deficiency (Brown-Vialetto-Van Laere syndrome, BVVLS).
Ceren Çıralı +8 more
openaire +1 more source
Human Mutation, 2010
Riboflavin, or vitamin B2, is a precursor to flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) molecules, required in biological oxidation-reduction reactions. We previously reported a case of a newborn female who had clinical and biochemical features of multiple acyl-CoA dehydrogenation deficiency (MADD), which was corrected by ...
Ho, Gladys +10 more
openaire +3 more sources
Riboflavin, or vitamin B2, is a precursor to flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) molecules, required in biological oxidation-reduction reactions. We previously reported a case of a newborn female who had clinical and biochemical features of multiple acyl-CoA dehydrogenation deficiency (MADD), which was corrected by ...
Ho, Gladys +10 more
openaire +3 more sources
Child Neurology: Five-Year Update on Siblings With Riboflavin Transporter Deficiency
NeurologyRiboflavin transporter deficiency (RTD), previously referred to as Brown-Vialetto-Van Laere syndrome, is caused by pathogenic variants in the SLC52A1, SLC52A2, or SLC52A3 genes, resulting in RTD types 1, 2, and 3, respectively. Researchers estimate an occurrence of approximately 1 in 1,000,000.
Marisa A. O'Brien +3 more
openaire +2 more sources
Riboflavin transporter deficiency
Neuromuscular Disorders, 2017Topaloglu, H. +4 more
openaire +3 more sources
Developmental Medicine & Child Neurology
This commentary is on the original article by Fennessy et al. on pages 405–415 of this issue.
Enrico Bertini, Keith Massey
openaire +2 more sources
This commentary is on the original article by Fennessy et al. on pages 405–415 of this issue.
Enrico Bertini, Keith Massey
openaire +2 more sources
Normal Outcome With Prenatal Intervention for Riboflavin Transporter Defect
Pediatric Neurology, 2023Jo Wilmshurst, Sharika Raga
exaly
The Clinical Journey of Patients with Riboflavin Transporter Deficiency Type 2
Journal of Child Neurology, 2020Fatima Amir, Lisa Hunter
exaly

